File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A Case of Primary Hepatic Neuroendocrine Tumor and Literature Review

TitleA Case of Primary Hepatic Neuroendocrine Tumor and Literature Review
Authors
Wong, PCShe, WHKhoo, USCheung, TT
KeywordsPrimary hepatic neuroendocrine tumor
Liver neoplasm
Carcinoid tumor
Issue Date2021
PublisherKarger Publishers Open Access. The Journal's web site is located at http://www.karger.com/CRO
Citation
Case Reports in Oncology, 2021, v. 14, p. 90-97 How to Cite?
DOI: http://dx.doi.org/10.1159/000510935
AbstractWe report an unusual presentation of primary hepatic neuroendocrine tumor which was initially misdiagnosed as intrahepatic cholangiocarcinoma. The diagnosis was only revealed after a major liver resection by histopathology. With adjuvant lanreotide injection, the patient survived for more than 16 months after the operation without tumor recurrence. Diagnosis of this rare tumor has been a major challenge and we emphasize the importance of a preoperative diagnosis. Surgical resection remains the mainstay for curative treatment, while peptide receptor radionuclide therapy is an emerging treatment option which has provided promising results. © 2021 The Author(s). Published by S. Karger AG, Basel
Persistent Identifierhttp://hdl.handle.net/10722/305038
ISSN
1662-6575
2020 SCImago Journal Rankings: 0.365
PubMed Central ID
PMC7983612
ISI Accession Number ID
WOS:000648553000016

 

DC FieldValueLanguage
dc.contributor.authorWong, PC-
dc.contributor.authorShe, WH-
dc.contributor.authorKhoo, US-
dc.contributor.authorCheung, TT-
dc.date.accessioned2021-10-05T02:38:52Z-
dc.date.available2021-10-05T02:38:52Z-
dc.date.issued2021-
dc.identifier.citationCase Reports in Oncology, 2021, v. 14, p. 90-97-
dc.identifier.issn1662-6575-
dc.identifier.urihttp://hdl.handle.net/10722/305038-
dc.description.abstractWe report an unusual presentation of primary hepatic neuroendocrine tumor which was initially misdiagnosed as intrahepatic cholangiocarcinoma. The diagnosis was only revealed after a major liver resection by histopathology. With adjuvant lanreotide injection, the patient survived for more than 16 months after the operation without tumor recurrence. Diagnosis of this rare tumor has been a major challenge and we emphasize the importance of a preoperative diagnosis. Surgical resection remains the mainstay for curative treatment, while peptide receptor radionuclide therapy is an emerging treatment option which has provided promising results. © 2021 The Author(s). Published by S. Karger AG, Basel-
dc.languageeng-
dc.publisherKarger Publishers Open Access. The Journal's web site is located at http://www.karger.com/CRO-
dc.relation.ispartofCase Reports in Oncology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectPrimary hepatic neuroendocrine tumor-
dc.subjectLiver neoplasm-
dc.subjectCarcinoid tumor-
dc.titleA Case of Primary Hepatic Neuroendocrine Tumor and Literature Review-
dc.typeArticle-
dc.identifier.emailKhoo, US: uskhoo@hku.hk-
dc.identifier.emailCheung, TT: cheung68@hku.hk-
dc.identifier.authorityKhoo, US=rp00362-
dc.identifier.authorityCheung, TT=rp02129-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1159/000510935-
dc.identifier.pmid33776688-
dc.identifier.pmcidPMC7983612-
dc.identifier.scopuseid_2-s2.0-85102122670-
dc.identifier.hkuros325905-
dc.identifier.volume14-
dc.identifier.spage90-
dc.identifier.epage97-
dc.identifier.isiWOS:000648553000016-
dc.publisher.placeSwitzerland-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats